Get started
Author

Elias Kouchakji

Observed names: E Kouchakji, E. Kouchakji, Kouchakji, E.
OpenAlex ID: A5091483020
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
2019 · Luca Richeldi, Evans R Fernández Pérez, et al. · The Lancet Respiratory Medicine · 291
Gemcitabine/nab-paclitaxel with pamrevlumab: a novel drug combination and trial design for the treatment of locally advanced pancreatic cancer
2020 · Vincent Picozzi, Adnan Alseidi, et al. · ESMO Open · 79
Quantitative CT analysis using functional imaging is superior in describing disease progression in idiopathic pulmonary fibrosis compared to forced vital capacity
2018 · J. Clukers, M. Lanclus, et al. · Respiratory Research · 40
PDF
Effect of anti-CTGF human recombinant monoclonal antibody pamrevlumab on resectability and resection rate when combined with gemcitabine/nab-paclitaxel in phase 1/2 clinical study for the treatment of locally advanced pancreatic cancer patients.
2018 · Vincent J. Picozzi, Michael J. Pishvaian, et al. · Journal of Clinical Oncology · 20
PRAISE, a randomized, placebo-controlled, double-blind Phase 2 clinical trial of pamrevlumab (FG-3019) in IPF patients
2017 · Eduard Gorina, Luca Richeldi, et al. · 19
Randomized, open-label trial of gemcitabine/nab-paclitaxel (G/NP) ± pamrevlumab (P) as neoadjuvant chemotherapy in locally advanced, unresectable pancreatic cancer (LAPC).
2017 · Vincent J. Picozzi, Flavio G. Rocha, et al. · Journal of Clinical Oncology · 11
Risk of Pure Red Cell Aplasia in Patients With Hepatitis C Receiving Antiviral Therapy and an Erythropoiesis-Stimulating Agent
2013 · Jerome Rossert, Susan Yue, et al. · Clinical Gastroenterology and Hepatology · 4
Late Intervention with Radiation-Induced Lung Fibrosis - Comparing Pamrevlumab Anti-CTGF Therapy vs. Pirfenidone vs. Nintedanib as Mono-, Dual- and Triple-therapy Combinations
2020 · M. Moustafa, K.E. Lipson, et al. · International Journal of Radiation Oncology*Biology*Physics · 3
PDF
Anti-CTGF human recombinant monoclonal antibody pamrevlumab increases resectability and resection rate when combined with gemcitabine/Nab-paclitaxel in the treatment of locally advanced pancreatic cancer patients
2017 · E. Carrier, V. Picozzi, et al. · Annals of Oncology · 3
PDF
Prognostic utility of inflammation biomarkers in a PDAC trial involving the human anti-CTGF antibody pamrevlumab.
2020 · Mark D. Sternlicht, Dongxia Li, et al. · Journal of Clinical Oncology · 2
Effect of pamrevlumab on the UCSD-SOBQ (University of California San Diego–Shortness of Breath Questionnaire) in patients with Idiopathic Pulmonary Fibrosis (IPF)
2018 · Eduard Gorina, Tro Sekayan, et al. · 2
Minimal Clinically Important Difference of HRCT Quantitative Lung Fibrosis Scores Anchored by St. George Respiratory Questionnaire and Forced Vital Capacity in Idiopathic Pulmonary Fibrosis
2021 · G.H.H. Kim, W. Chou, et al. · 1
PDF
PRAISE IPF study correlation between quantitative lung fibrosis (QLF) measured by quantitative high resolution computed tomography (qHRCT) and quality of life (QoL) assessed by St. George’s respiratory questionnaire (SGRQ)
2019 · Elias Kouchakji, Jonathan Goldin, et al. · 1
Gemcitabine/Nab-Paclitaxel and Pamrevlumab in Locally Advanced Pancreatic Cancer (LAPC): A Phase 1/2 Trial
2019 · Vincent Picozzi, Flavio Rocha, et al. · SSRN Electronic Journal · 1
Pamrevlumab (FG-3019), an Anti-Connective Tissue Growth Factor Therapy for Idiopathic Pulmonary Fibrosis: A Randomized, Double-Blind, Placebo-Controlled Trial
2019 · Luca Richeldi, Evans R. Fernández Pérez, et al. · SSRN Electronic Journal · 1
Late Breaking Abstract - Assessment of disease progression in IPF patients using Functional Respiratory Imaging (FRI)
2017 · Maarten Lanclus, Seth Porter, et al. · 1
Safety and efficacy of pamrevlumab (FG-3019) in patients with COVID-19 pneumonia: an open-label, randomized, parallel-arm phase 2 study
2022 · G Sgalla, J Simonetti, et al. · 10.01 - Respiratory infections and bronchiectasis
Connective tissue growth factor (CTGF) methylation status is associated with prognosis of patients with head and neck squamous cell carcinoma (HNSCC) treated with radiochemotherapy (RCHT): A multicenter study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
2019 · Bouchra Tawk, Christian Schwager, et al. · Journal of Clinical Oncology
機能的イメージングを用いた定量的ct分析は,強制された生体能力と比較した特発性肺線維症における疾患進行の記述に優れている【jst・京大機械翻訳】
2018 · J Clukers, M Lanclus, et al.
Late Breaking Abstract - Responder phenotyping using functional respiratory imaging (FRI) in IPF patients treated with anti-CGTG monoclonal antibody FG3019
2017 · Charles Mussche, Cedric Van Holsbeke, et al.
S1044 Natalizumab Use in Patients with Crohn's Disease and Relapsing Multiple Sclerosis: Updated Utilization and Safety Results from the Touch™ Prescribing Program, the Pregnancy Registry, and the Inform and Tygris Studies
2009 · Bruce E. Sands, Mariska Kooijmans, et al. · Gastroenterology
Works count: 23
Citation count: 479
H-index: 6
I10-index: 6
Year
Topic
Type